biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Protalix

<< Previous

Bullboard Posts

Next >>

Comment by Aarcoron Apr 04, 2022 6:19pm

100 Views

Post# 34574840

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Protalix

SimpSniper, we're all just waiting. You have "high expectations". Why ? This management's past performance has not produced anything except a declining share price. I know you can't understand it, but handing over control of your objectives, and waiting on another org to save you, is not a sound business plan - that's why we're all just waiting.

Now, be quiet, go back to your primary assignment and get to upvoting JD's posts.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property